Perrigo said Friday that it would not comment on "speculation or market rumor."
The new mouse model is significant because it closely replicates the symptoms and gene expression patterns found in people who have the most common genetic cause of ALS.
Melbourne researchers have uncovered the genes responsible for the way the body fights infection at the point of 'invasion'.
The first U.N. General Assembly special session to address global drug policy in nearly 20 years heard major differences on the approach to drug use on its second day on Wednesday.
This is the first molecular model of this critical transporter, and could prove important for the development of therapeutic agents that need to be delivered to the brain.
The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.
Genes and environment determine short-sightedness.
Shares of Novartis were down 0.7 percent at 74.55 Swiss francs in mid-morning trading on the Six Swiss stock exchange.
The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.
Alcohol and bacon are some of the key culprits.
Asthma is a chronic condition that affects more than 25 million people in the United States alone.
Under the terms of the agreement, argenx will conduct research and development through IND-enabling studies.
Novartis published their first quarter financial report, which included information on bimagrumab, a drug developed in conjunction with Morphosys to treat a muscle-wasting disease called sporadic inclusion body myositis (sIBM).
This disease marks the third treatment indication GW is pursuing.
A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.